Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

OMDA Aktie

>OMDA Performance
1 Woche: 0%
1 Monat: -9,2%
3 Monate: +16,2%
6 Monate: +64,0%
1 Jahr: +37,9%
laufendes Jahr: +64,0%
>OMDA Aktie
Name:  OMDA AS NK 10
Land:  Norwegen
Sektor:  Gesundheit
ISIN/ Wkn:  NO0010894512 / A2QD8B
Symbol/ Ticker:  6Q1 (Frankfurt)
Kürzel:  FRA:6Q1, ETR:6Q1, 6Q1:GR
Index:  -
Webseite:  https://omda.com/
Marktkapitalisierung:  89.43 Mio. EUR
Umsatz:  382.8 Mio. EUR
EBITDA:  35.86 Mio. EUR
Gewinn je Aktie:  -0.165 EUR
Schulden:  419.56 Mio. EUR
Liquide Mittel:  51.94 Mio. EUR
Umsatz-/ Gewinnwachstum:  15% / -
KGV/ KGV lG:  7.3 / -
KUV/ KBV/ PEG:  2.22 / 30.02 / -
Gewinnm./ Eigenkapitalr.:  -10.32% / -77.35%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / 1.2%
Insiderhandel:  -
Suchwörter:  OMDA
Letzte Datenerhebung:  05.07.25
>OMDA Eigentümer
Aktien: 20.51 Mio. St.
f.h. Aktien: 7.04 Mio. St.
Insider Eigner: 42.61%
Instit. Eigner: 4.93%
Leerverk. Aktien: -
>OMDA Peer Group

 
11.06.25 - 18:06
Should You Buy Omada Health Stock After the OMDA IPO? (Barchart)
 
The health tech company is currently trading below its IPO price of $23 per share....
06.06.25 - 02:51
Omada Health Announces Pricing of Initial Public Offering (Business Wire)
 
SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, the virtual between-visit healthcare provider, today announced the pricing of its initial public offering of 7,900,000 shares of its common stock, at a public offering price of $19.00 per share. In addition, Omada Health has granted the underwriters a 30-day option to purchase up to an additional 1,185,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market on June 6, 2025, under the ticker symbol “OMDA.” The offering is expected to close on June 9, 2025, subject to customary closing conditions. Morgan Stanley, Goldman Sachs & Co. LLC and J.P. Morgan are acting as lead book-running managers for the proposed offering. Barclays and Evercore ISI are acting as joint book-running managers for the proposed offering. Canaccord Genuity and Needham & Company are acting as co-managers for the proposed offering. A registration statement re...
29.05.25 - 12:15
Omada Health Announces Launch of Initial Public Offering (Business Wire)
 
SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, the virtual between-visit healthcare provider, announced today that it has launched the roadshow for its proposed initial public offering of its common stock. Omada Health has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) to offer an aggregate of 7,900,000 shares of its common stock. In addition, Omada Health intends to grant the underwriters a 30-day option to purchase up to an additional 1,185,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is expected to be between $18.00 and $20.00 per share. Omada Health has applied to list its common stock on the Nasdaq Global Market under the ticker symbol “OMDA.” Morgan Stanley, Goldman Sachs & Co. LLC, and J.P. Morgan are acting as lead book-running managers for the proposed offering. Barclays and Evercore ISI are acting as joint book-running managers for the...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Kein Kaiser kann, was unser ist, verschenken. - Friedrich Johann Christoph Schiller
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!